GlassScriptPhysician profile
Noah J Fitzpatrick
NPI 1619942851
$1,486.59
in general payments reported to CMS, 2019-2025
19 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $122 · 2021: $73.77 · 2022: $188 · 2023: $264 · 2024: $353 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $552.42 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $149.79 | 2021-2025 | Airsupra, Farxiga |
| Abbvie INC. | $105.23 | 2021-2024 | |
| Glaxosmithkline, LLC. | $101.78 | 2019-2023 | Shingrix, Arexvy |
| Amgen INC. | $93.60 | 2020-2025 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $71.83 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $67.35 | 2019-2022 | |
| Lilly USA, LLC | $58.08 | 2019-2025 | Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.60 | 2019-2024 | Synjardy, Jardiance |
| Dexcom, INC. | $38.62 | 2024 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $33.45 | 2019-2024 | Eliquis |
| Pulmonx Corporation | $30.86 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Endogastric Solutions, INC | $30.00 | 2024 | Esophyx |
| Novo Nordisk INC | $27.91 | 2019-2020 | |
| Horizon Therapeutics Plc | $20.58 | 2023 | Krystexxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $19.46 | 2019 | |
| Abbott Laboratories | $18.18 | 2024 | Freestyle Libre |
| Daiichi Sankyo INC. | $12.56 | 2020 | |
| Allergan, INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Fitzpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.